Search Results 31-40 of 3456 for Solid

1. DCSZ11 as a Monotherapy in Patients With Advanced or Metastatic Solid Tumors - Mayo Clinic

   The purpose of this study is to assess the effects of DCSZ11, an anti-CD93 monoclonal antibody, as a monotherapy in patients with advanced or metastatic solid ...

2. Phase 1/2 Study Of MRTX1719 In Solid Tumors With MTAP Deletion - Mayo Clinic

   The purpose of this study is to to characterize the safety, tolerability, and pharmacokinetics of MRTX1719 in patients with advanced solid tumor malignancies ...

3. Solid Tumor Monoclonal B-cell Lymphocytosis Screening - Mayo Clinic

   Less than 40 years old, no recent solid tumor diagnosis, history of hematologic malignancy. Note: Other protocol defined Inclusion/Exclusion criteria may apply.

4. Pafolacianine for Localization of Pediatric Extracranial Solid Tumors - Mayo Clinic

   ... solid tumors. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...

5. Study Of IBI3020 Treatment In Participants With Late-Stage Solid Tumors - Mayo Clinic

   The main purpose of this study is to evaluate the safety and tolerability of IBI3020 and to determine the maximum tolerated dose (MTD) and/or the recommended ...

6. A Phase I Study of TAS-102 in Patients with Advanced Solid Tumors with Hepatic Impairment - Mayo Clinic

   Study to evaluate the safety, tolerability, and pharmacokinetics of TAS-102 in patients with advanced solid tumors and varying degrees of hepatic impairment.

7. A Study of SC‑004 in Subjects With Advanced Solid Tumors - Mayo Clinic

   Part A (dose regimen finding) will allow definition of the maximum tolerated dose (MTD) through dose escalation and possible dose interval modification. In Part ...

8. Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors - Mayo Clinic

   This phase I trial studies the side effects and best dose of veliparib when given together with liposomal irinotecan in treating patients with solid tumors.

9. Symptoms, Sleep Characteristics, and Disability in Solid Organ Transplant Recipients - Mayo Clinic

   ... solid organ transplantation. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...

10. First In Human Study Of TUB-030 In Patients With Advanced Solid Tumors - Mayo Clinic

    About this study. The goal of this clinical trial is to learn if the drug TUB-030 works to treat solid cancer in adults. The study will also explore the ...